Demographics (2)
- AGE - Subject age at enrollment (phv00496302.v1.p1)
- SEX - Biological sex (phv00496298.v1.p1)
Disease Events (3)
- AFFECTION_STATUS - Case control status of the subject for Human Leukocyte Antigen Loss of Heterozygosity (HLA LOH); all subjects are HLA LOH patients. (phv00496304.v1.p1)
- HISTOLOGICAL_TYPE - Histological type (phv00496308.v1.p1)
- TUMOR_STAGE - Tumor stage at treatment start (phv00496309.v1.p1)
Race and Ethnicity (1)
- ETHNICITY - Self-reported ethnicity (phv00496303.v1.p1)
Other (8)
- ANALYTE_TYPE - Analyte Type (phv00496306.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00496297.v1.p1)
- IS_TUMOR - Tumor status (phv00496307.v1.p1)
- SAMPLE_ID - Sample ID (phv00496305.v1.p1)
- SAMPLE_ID - Sample ID (phv00496300.v1.p1)
- SUBJECT_ID - Subject ID (phv00496301.v1.p1)
- SUBJECT_ID - Subject ID (phv00496296.v1.p1)
- SUBJECT_ID - Subject ID (phv00496299.v1.p1)